93.48 USD
↗ 0.99 (1.07%)AT CLOSE (11:59 AM EDT)
Mirum Pharmaceuticals, Inc. Common Stock
MIRMNASDAQ • USD
92.76
↘ 0.73 (0.78%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
92.76
↘ 0.73 (0.78%)
Market: CLOSED
Open?$92.42
High?$94.05
Low?$91.89
Prev. Close?$92.49
Volume?585.3K
Avg. Volume?1.1M
VWAP?$93.23
Rel. Volume?0.54x
Bid / Ask
Bid?$91.00 × 100
Ask?$95.25 × 200
Spread?$4.25
Midpoint?$93.13
Valuation & Ratios
Market Cap?5.7B
Shares Out?61.0M
Float?48.8M
Float %?80.9%
P/E Ratio?N/A
P/B Ratio?23.51
EPS?-$13.10
Dividend?0.00%
Ex-Dividend?N/A
MIRM is currently priced at $93.48. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, MIRM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Employees
418
Market Cap
5.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-07-18
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085
FOSTER CITY, CA 94404
Phone: 650-667-4085
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?12
Momentum?79
Short Sent.?31
Piotroski F-Score?3/9Weak
Altman Z-Score?1.07Distress
Confidence?60%Moderate
Short InterestHigh
Short % of Float?16.79%High
Short Interest?8.2M
Days to Cover?4.8
Free Float48.8M
Avg Daily Volume1.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.09Strong
Quick Ratio?1.99Adequate
Cash Ratio?1.19Strong
Debt/Equity?1.28Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?23.51HIGH▾
Peers100
S&P3
P/S?10.01HIGH▾
Peers100
S&P8
P/FCF?N/A▾
EV/EBITDA?-7.4CHEAP▾
S&P97
EV/Sales?9.98HIGH▾
Peers100
S&P11
Returns & Efficiency
ROE?-329.4%WEAK▾
S&P3
ROA?-89.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-172552000
Enterprise Value?$5.7B
Fundamentals ratios updated end of day